National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/15/2021 release of VAERS data:

Found 416 cases where Symptom is Aborted pregnancy or Abortion or Abortion complete or Abortion early or Abortion incomplete or Abortion induced or Abortion late or Abortion missed or Abortion of ectopic pregnancy or Abortion spontaneous or Abortion spontaneous complete or Abortion spontaneous incomplete or Foetal cardiac arrest or Foetal death or Premature baby death or Premature delivery or Stillbirth and Vaccination Date from '2015-01-01' to '2020-12-31'

Table

   
Year of VaccinationCountPercent
20155412.98%
2016419.86%
2017307.21%
20187618.27%
20199121.88%
202012429.81%
TOTAL416100%



Case Details

This is page 1 out of 42

Result pages: 1 2 3 4 5 6 7 8 9 10   next


VAERS ID: 571849 (history)  
Form: Version 1.0  
Age: 29.0  
Sex: Female  
Location: Unknown  
Vaccinated:2015-02-24
Onset:2015-03-08
   Days after vaccination:12
Submitted: 2015-03-30
   Days after onset:21
Entered: 2015-03-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS - / UNK UN / SYR

Administered by: Other       Purchased by: Other
Symptoms: Abortion spontaneous, Blood test abnormal, Exposure during pregnancy, Pregnancy test positive
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), Normal pregnancy conditions and outcomes (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Propylthiouracil; Prenatal vitamins
Current Illness: Unknown
Preexisting Conditions: Basedow''s disease
Allergies:
Diagnostic Lab Data: 03/04/2015, Blood test, Abnormal, Significant, Non-viable
CDC Split Type: PHEH2015US005313

Write-up: Case number PHEH2015US005313, is an initial spontaneous report from a consumer (patient) received on 17 Mar 2015 and with follow up information received from the quality assurance department (QA reference number: 358730) on 20 Mar 2015 and a follow up received from nurse on 20 Mar 2015, with the follow-up information received from Quality Assurance Department (reference number: 358730) on 26 Mar 2015. This report refers to a 29 years old female pregnant patient. Past medical history included Graves'' disease. Concomitant medications included propylthiouracil and prenatal vitamins. The patient was vaccinated with BEXSERO (batch number: unknown) on 24 Feb 2015. On 04 Mar 2015, the patient underwent blood test which confirmed non-viable (not further specified). The patient''s pregnancy was confirmed by quantitative lab work (possible chemical pregnancy). However, no ultrasound was done to confirm the pregnancy. The patient''s last menstrual period (LMP) was on 28 Jan 2015 and expected date of delivery (EDD) was 04 Nov 2015. On 08 Mar 2015, the patient had a miscarriage. The patient''s pregnancy was not associated with any contraception failure and the patient did not discontinue any drugs due to the pregnancy. The patient had now recovered and was now having regular menses. Seriousness and causality of the events was not reported. Seriousness assessment of miscarriage was upgraded based on the NVS-IMS list. On the basis of the review performed it is possible to confirm that BEXSERO manufacturing process is under control. From a technical and quality point of view, neither any objection nor discrepancy has been identified nor was any cause identified for the reported adverse event. Non-significant follow up information received from the quality assurance department (QA reference number: 358730) on 20 Mar 2015: Updated QA reference number. Follow up received from nurse on 20 Mar 2015: updated patient demographics, medical history, concomitant medications, LMP, EDD and other clinically relevant information in the narrative. Follow-up information received from the Quality Assurance Department (reference number: 358730) on 26 Mar 2015: Updated BEXSERO batch review report.


VAERS ID: 575509 (history)  
Form: Version 1.0  
Age: 16.0  
Sex: Female  
Location: Unknown  
Vaccinated:2015-02-03
Onset:0000-00-00
Submitted: 2015-04-27
Entered: 2015-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. J012212 / 1 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Abortion spontaneous, Exposure during pregnancy, Pregnancy test positive, Uterine dilation and curettage
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), Normal pregnancy conditions and outcomes (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Pregnancy
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: 02/03/2015, Pregnancy test, negative; 02/25/2015, Pregnancy test, positive
CDC Split Type: WAES1504USA020670

Write-up: This spontaneous retrospective pregnancy report as received from a nurse practitioner refers to an approximately 16 year old female patient. No medical history and current conditions were reported. On 03-FEB-2015 patient was given an unspecified pregnancy test which came back negative. On 03-FEB-2015 (reported as on the same visit) the patient was vaccinated with first dose of GARDASIL (lot # J012212, expiry: 18-FEB-2016) (dosing regimen and frequency unknown). It was also reported the product was confirmed as GARDASIL and not GARDASIL 9. No concomitant medications were reported. On 25-FEB-2015, the patient came back to office due to lack of menstrual period and suspicion of pregnancy and the patient underwent another unspecified pregnancy test which came back positive. The nurse reported that at that time it had been 6 weeks since the patient''s last menstrual period. The patient became pregnant with Last Menstrual Period of 14-JAN-2015 and Estimated Date of Delivery of 21-OCT-2015. The date of conception was 28-JAN-2015. Nurse practitioner reported that the patient was then seen at an unspecified medical center on 01-APR-2015 due to miscarriage, where an outpatient Uterine dilation and curettage was performed. It was reported that the patient sought medical attention. The action taken with the therapy with GARDASIL was unknown. The outcome of the events was unknown. The reporter causality was not provided. No product quality complaint was involved. Additional information has been requested.


VAERS ID: 577919 (history)  
Form: Version 1.0  
Age: 27.0  
Sex: Female  
Location: Minnesota  
Vaccinated:2015-05-08
Onset:2015-05-11
   Days after vaccination:3
Submitted: 2015-05-12
   Days after onset:1
Entered: 2015-05-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
UNK: VACCINE NOT SPECIFIED (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK - / -

Administered by: Other       Purchased by: Other
Symptoms: Abortion spontaneous, Arthralgia, Myalgia
SMQs:, Rhabdomyolysis/myopathy (broad), Eosinophilic pneumonia (broad), Termination of pregnancy and risk of abortion (narrow), Arthritis (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: No
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Miscarriage, muscle pain, joint pain.


VAERS ID: 587784 (history)  
Form: Version 1.0  
Age: 17.0  
Sex: Female  
Location: Arizona  
Vaccinated:2015-06-29
Onset:2015-07-09
   Days after vaccination:10
Submitted: 2015-07-29
   Days after onset:20
Entered: 2015-07-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. K008625 / 2 RA / SC

Administered by: Public       Purchased by: Public
Symptoms: Abortion spontaneous, Exposure during pregnancy, Feeling cold, Hot flush, Mobility decreased, Musculoskeletal disorder, Nausea, Rubella antibody positive, Seizure, Vaginal discharge
SMQs:, Rhabdomyolysis/myopathy (broad), Acute pancreatitis (broad), Systemic lupus erythematosus (broad), Convulsions (narrow), Parkinson-like events (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), Generalised convulsive seizures following immunisation (narrow), Tendinopathies and ligament disorders (broad), Hypoglycaemia (broad), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: None
Current Illness: None known
Preexisting Conditions: Was pregnant at the time vaccinated, though patient didn''t know it at the time. Has history of asthma. Allergy to PNC and Tylenol Products.
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type:

Write-up: Woke up that morning to hot and cold flashes, extreme nausea and vaginal discharge. Started having "joint seizures" to the point she couldn''t move her hands. Lost full function of the hands, but was systemic to all joints in body. Lasted 2 hours. Went to the ER. They were vague, stated they couldn''t link symptoms directly to vaccination. Went to her PCP. Patient didn''t realize she was pregnant, but miscarried on 7/12/15. Her PCP felt her symptoms and miscarriage were related to MMR vaccination. "PCP drew MMR titer, and patient claims her Rubella titer returned with extremely high numbers. The other components of the titer were in normal ranges. My PCP feels I''m extremely susceptible to Rubella vaccination and should claim medical exemption". Episode lasted 4 days total.


VAERS ID: 595274 (history)  
Form: Version 1.0  
Age: 30.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2015-03-05
Onset:2015-04-24
   Days after vaccination:50
Submitted: 2015-09-03
   Days after onset:132
Entered: 2015-09-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
TDAP: TDAP (BOOSTRIX) / GLAXOSMITHKLINE BIOLOGICALS 7535X / UNK UN / IM

Administered by: Private       Purchased by: Private
Symptoms: Caesarean section, Expired product administered, Exposure during pregnancy, Premature delivery
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US2015030093

Write-up: This is a prospective pregnancy case. This 30-year-old female subject was enrolled in an open label study. The subject received BOOSTRIX (intramuscular) .5 ml on 5th March 2015 13:30. The subject''s last menstrual period was on 14 August 2014 and estimated date of delivery was 21st May 2015. The subject received BOOSTRIX at week 29 of the pregnancy and during the third trimester of pregnancy. On an unknown date, an unknown time after receiving BOOSTRIX, the subject developed vaccine exposure during pregnancy (Non-serious). Additional event(s) included expired vaccine used. The outcome of vaccine exposure during pregnancy was unknown. The outcome(s) of the additional event(s) included vaccine used (unknown). The pregnancy was ongoing. Additional information: The last menstrual period was not reported but was calculated with the due date. The vaccine was expired since 15 February 2015. Follow-up information received on 14 July 2015: The pregnancy resulted in a live neonate with no apparent congenital anomaly. On 24th April 2015 after 36 weeks and 1 day, 50 days after receiving BOOSTRIX the subject gave birth to a male neonate via cesarean delivery. The neonate weighed 2268 grams (5 lbs) at birth and lengthed 50 cm. APGAR scores were 8 and 9. It was unknown if the investigator considered the live birth and premature labor to be related to BOOSTRIX.


VAERS ID: 601370 (history)  
Form: Version 1.0  
Age: 21.0  
Sex: Female  
Location: Ohio  
Vaccinated:2015-03-17
Onset:2015-04-14
   Days after vaccination:28
Submitted: 2015-10-01
   Days after onset:170
Entered: 2015-10-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
TDAP: TDAP (BOOSTRIX) / GLAXOSMITHKLINE BIOLOGICALS 95L3P / UNK UN / IM

Administered by: Private       Purchased by: Private
Symptoms: Exposure during pregnancy, Foetal disorder, Premature delivery
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Foetal disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US2015GSK035278

Write-up: This is a prospective pregnancy case. This 21-year-old female subject was enrolled in a study to detect and described any abnormal pregnancy outcomes in women intentionally or unintentionally vaccinated with BOOSTRIX during pregnancy or within 28 days preceding conception. The subject received BOOSTRIX (intramuscular) .5 ml on 17th March 2015. The subject''s last menstrual period was on 19th August 2014 and estimated date of delivery was 26th May 2015. The subject received BOOSTRIX at week 30 of the pregnancy and during the third trimester of pregnancy. On 17th March 2015, an unknown time after receiving BOOSTRIX, the subject developed vaccine exposure during pregnancy (non-serious). The outcome of vaccine exposure during pregnancy was unknown. The pregnancy was ongoing. It was unknown if the investigator considered the vaccine exposure during pregnancy to be related to BOOSTRIX. Additional details were provided as follows: This was a normal conception. Follow-up information received on 28 April 2015 from nurse: Some of the patient''s details were provided. The VAERS details were provided. Follow-up information received on 30 September 2015 form nurse: The subject had no previous pregnancies. 28 days after receiving BOOSTRIX and after 34 weeks of gestation, the subject gave premature birth to a female neonate via vaginal delivery with no apparent congenital anomaly. The neonate weighed 1831 grams (4lbs 1oz) at birth. APGAR scores were 8/9. It was unknown if the reporter considered the live birth to be related to BOOSTRIX$g


VAERS ID: 598619 (history)  
Form: Version 1.0  
Age: 39.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2015-09-25
Onset:2015-09-25
   Days after vaccination:0
Submitted: 2015-10-05
   Days after onset:10
Entered: 2015-10-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU4: INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) / SANOFI PASTEUR UI433AA / UNK RA / IM

Administered by: Private       Purchased by: Other
Symptoms: Abortion spontaneous, Arthralgia, Blood test, Exposure during pregnancy, Haemorrhage, Joint stiffness, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Ultrasound scan
SMQs:, Rhabdomyolysis/myopathy (broad), Haemorrhage terms (excl laboratory terms) (narrow), Dystonia (broad), Parkinson-like events (broad), Noninfectious encephalitis (broad), Noninfectious meningitis (broad), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), Arthritis (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: Miscarriage~Influenza (Seasonal) (no brand name)~~39.58~Patient
Other Medications: Nexium 20 Mg
Current Illness: Pain and stiffness in thumb joint and shoulder, cramping, bleeding and miscarriage in the early evening
Preexisting Conditions: Pregnancy, First Trimester
Allergies:
Diagnostic Lab Data: Ultrasounds, blood work
CDC Split Type:

Write-up: Stiffness and pain in thumb joint and shoulder, cramping and bleeding and miscarriage. Treated for miscarriage at ER on 9/26/2015.


VAERS ID: 601607 (history)  
Form: Version 1.0  
Age: 28.0  
Sex: Female  
Location: Unknown  
Vaccinated:2015-07-31
Onset:2015-08-19
   Days after vaccination:19
Submitted: 2015-10-01
   Days after onset:43
Entered: 2015-10-09
   Days after submission:8
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RAB: RABIES (RABAVERT) / NOVARTIS VACCINES AND DIAGNOSTICS - / 2 UN / SYR

Administered by: Other       Purchased by: Other
Symptoms: Abortion spontaneous, Exposure during pregnancy, Haemorrhage
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: 07/26/2015, Animal bite
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: PHEH2015US019301

Write-up: Case number PHEH2015US019301, is an initial spontaneous report from consumer (patient) received on 25 Sep 2015. This report refers to a 28 years old female pregnant patient. Medical history and concomitant medications were not reported. She was bitten by bat on 26 Jul 2015. She was vaccinated with first dose of post exposure of RABAVERT (batch number: not reported) on 28 Jul 2015. She did not know she was pregnant at the time of vaccination. She found out on 31 Jul 2015 and her health care professional advised her to continue remaining vaccines. She was vaccinated with second dose of RABAVERT (batch number: not reported) on 31 Jul 2015. On the same day (31 Jul 2015) she experienced bleeding and miscarried on 19 Aug 2015. Outcome of the event bleeding was reported as recovered on 19 Aug 2015 and outcome of other event was not reported. The reporter assessed the events serious (medically significant). Causality of the events was not reported. The case was lost to follow-up.


VAERS ID: 601656 (history)  
Form: Version 1.0  
Age: 18.0  
Sex: Female  
Location: Unknown  
Vaccinated:2015-09-29
Onset:0000-00-00
Submitted: 2015-10-09
Entered: 2015-10-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 3 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Abortion spontaneous, Endocrine test abnormal, Exposure during pregnancy, Haematology test, Laboratory test, Muscle spasms, Pregnancy test positive, Urinary tract infection, Urine analysis, Vaginal haemorrhage
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Dystonia (broad), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow), Normal pregnancy conditions and outcomes (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Pregnancy test (30-SEP-2015): positive; 10/04/2015, Endocrine test, very low; 09/29/2015, Pregnancy test, the line was so faint-results were inconclusive
CDC Split Type: WAES1510USA002539

Write-up: This spontaneous retrospective pregnancy report as received from the patient''s mother refers to a 18 year old female patient. The patient had no pertinent medical history and no drug reactions or allergies. On unknown dates (reported as "when she was in 8th grade"), the patient received the first and the second dose of GARDASIL (dose, route, lot# and expiry date were not reported). On 29-SEP-2015, the patient was vaccinated with the third dose of GARDASIL (dose, route, lot# and expiry date were not reported). No concomitant medications were administered. The patient became pregnant with last menstrual period (LMP) of 01-SEP-2015 (menstruation through 07-SEP-2015) and estimated date of delivery (EDD) of 07-JUN-2016. Initial exposure to GARDASIL was at 4 weeks (it was also reported by the patient''s mother that "she could be 2-3 weeks pregnant"). On 29-SEP-2015, the patient performed multiple pregnancy tests, but the results were inconclusive, because the line was "so faint". On 30-SEP-2015, the patient was seen by the nurse practitioner and the pregnancy test was performed with a positive result. On 04-OCT-2015 (reported as "yesterday"), the patient was taken to the hospital (but per patient''s mother she was not admitted to the hospital) due to vaginal bleeding and cramping. General hematology, general chemistry, urinalysis and other laboratory studies were performed in the hospital (results were not provided). The patient''s hormone levels were also measured and they were very low, so the physicians thought that the patient lost the baby. Therefore the pregnancy outcome was spontaneous abortion unspecified date in 2015. Fetal outcome was not reported. On an unknown date in 2015, the patient developed urinary tract infection and unspecified medications were prescribed at the hospital for the treatment. At the time of report, the patient was still experiencing bleeding and cramping and the urinary tract infection was not completely resolved. The outcome of abortion spontaneous was unknown. The relatedness between the events and GARDASIL was not reported. Upon internal review the events of spontaneous abortion was considered to be medically significant. Additional information has been requested.


VAERS ID: 602794 (history)  
Form: Version 1.0  
Age: 24.0  
Sex: Female  
Location: Kentucky  
Vaccinated:2015-06-26
Onset:2015-08-09
   Days after vaccination:44
Submitted: 2015-10-15
   Days after onset:67
Entered: 2015-10-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. K007108 / UNK RA / SC

Administered by: Public       Purchased by: Other
Symptoms: Abortion spontaneous, Exposure during pregnancy
SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Termination of pregnancy and risk of abortion (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: None
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: NONE
CDC Split Type:

Write-up: MISCARRAGE.


Result pages: 1 2 3 4 5 6 7 8 9 10   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=VACY&EVENTS=ON&SYMPTOMS[]=Aborted+pregnancy+%2810000209%29&SYMPTOMS[]=Abortion+%2810000210%29&SYMPTOMS[]=Abortion+complete+%2810061614%29&SYMPTOMS[]=Abortion+early+%2810052846%29&SYMPTOMS[]=Abortion+incomplete+%2810000217%29&SYMPTOMS[]=Abortion+induced+%2810000220%29&SYMPTOMS[]=Abortion+late+%2810052847%29&SYMPTOMS[]=Abortion+missed+%2810000230%29&SYMPTOMS[]=Abortion+of+ectopic+pregnancy+%2810066266%29&SYMPTOMS[]=Abortion+spontaneous+%2810000234%29&SYMPTOMS[]=Abortion+spontaneous+complete+%2810061616%29&SYMPTOMS[]=Abortion+spontaneous+incomplete+%2810061617%29&SYMPTOMS[]=Foetal+cardiac+arrest+%2810084280%29&SYMPTOMS[]=Foetal+death+%2810055690%29&SYMPTOMS[]=Premature+baby+death+%2810076700%29&SYMPTOMS[]=Premature+delivery+%2810036595%29&SYMPTOMS[]=Stillbirth+%2810042062%29&VAX_YEAR_LOW=2015&VAX_YEAR_HIGH=2020&VAX_MONTH_HIGH=12

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166